Evaluation of the Safety and Efficacy of NBL-015 in Patients With Advanced Solid Tumors

NCT05153096 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

410

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Solid Tumors

Interventions

DRUG: NBL-015

Sponsor

NovaRock Biotherapeutics, Ltd